Search

Search Constraints

You searched for: Author/Creator Alroughani, Raed

Search Results

11. Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. (9th November 2021)

12. Comparative effectiveness in multiple sclerosis: A methodological comparison. (March 2023)

13. Comparative effectiveness of cladribine tablets versus other oral disease-modifying treatments for multiple sclerosis: Results from MSBase registry. (February 2023)

14. Comparing switch to ocrelizumab, cladribine or natalizumab after fingolimod treatment cessation in multiple sclerosis. Issue 12 (19th October 2022)

15. Comparison of fingolimod, dimethyl fumarate and teriflunomide for multiple sclerosis. Issue 4 (13th January 2019)

16. Confirmed disability progression as a marker of permanent disability in multiple sclerosis. (9th June 2022)

17. Contribution of different relapse phenotypes to disability in multiple sclerosis. (February 2017)

18. Corrigendum to Longitudinal machine learning modeling of MS patient trajectories improves predictions of disability progression: [Computer Methods and Programs in Biomedicine, Volume 208, (September 2021) 106180]. (January 2022)

19. Determinants of therapeutic lag in multiple sclerosis. (October 2021)

20. Diagnosis and classification of optic neuritis. Issue 12 (December 2022)